7[7]Chen A,Galloaway M,Landreneau R et al.Intrperative125I brachytherapy for high-risk stage Inon-small cell lung carcinoma [J]Int Radait Oncol Bio Phys,1999,44:1057～1063.
1Beyer DC, Puente F, Rogers KL, et al. Prostate brachy therapy: comparison of dose distribution with different 125Ⅰ source designs[J]. Radiology, 2001, 221 (3) :623.
2Ankem MK, DeCarvalho VS, Harangozo AM, et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy[J]. Urology, 2002,59 (4): 555.
3Raben A, Mychalczak B. Brachy-therapy for non-small cell lung cancer and selected neoplasms of the chest[J]. Chest, 1997,112: 276s.
4Chen A, Galloway M, Landreneau R, et al. Intraopera tive 125Ⅰbrachytherapy for high-risk stage Ⅰ non-small cell lung carcinoma[J]. Int J Radiat Oncol Biol Phys,2000 ,6(4): 1083.
5Mlhirddin M,Rosato F,Barbot D,et al.Long-term releases of combined modality treatment with 125I implantation for carcinoma of the pancreas.J Radiat Oncol Biol Phys,1992,23(3):305
7Hilaris BS,Nori D,Martine N.Results of radiation therapy in stage I and II unresectable non-small cell lung cancer.Endocureither Hypertherm Oncol,1986,2:15-21.
8Hilaris BS, Martine N.Interstitial brachytherapy in cancer of the lung:20 year experience.Int J Radiat Oncol Biol Phys,1979,5:1956-1976.
9Hilaris BS, Nori D. Brachytherapy oncology:Advances in lung and other cancers.New York:Memorial Sloan-Kettering Cancer Center,1982,8:767-771.
10Hilaris BS, Nori D,Beattie FJ,et al.Value of perioperative brachytherapy in the management of non-small cell carcinoma of the lung.Int J Radiat Oncol Biol Phys,1983,9:1161-1166.
8d'Amato TA, Galloway M, Szydlowski G, et al. Intraoperative brachytherapy following thoracoscopic wedge resection ofstage I lung cancer[ J ].Chest,1998, 114(4): 1112-1115.
9Fontanesi J , Heideman RL , Muhlbauer M, et al. High - activity ^125I interstitialir radiation in the treatment of pediatric central nervous systemtumors : apilot study[ J ]. Pediatr Nearosarg, 1995 ,22:289 - 297.
10Santos R, Colonias A, Parda D, et al. Comparison between sublobm" resection and 125iodine brachytherapy aftersublobar resection in high - risk patients with Stage I non - small - cell lung cancer[J]. Surgery, 2003,134(4) : 691-697.
